Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma

Gut

Volumn 48, Issue 1, 2001, Pages 80-86

  Chariyalertsak, S ^a   Sirikulchayanonta, V ^b   Mayer, D ^c   Kopp Schneider, A ^c   Furstenberger G ^c   Marks, F ^a   Muller Decker K ^a  

^a NATIONAL CANCER INSTITUTE   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Bile duct; Cholangiocarcinoma; Cyclooxygenase; Hepatocyte; Immunohistochemistry; Kupffer cell

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KUPFFER CELLS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STATISTICS, NONPARAMETRIC;

EID: 0035164443     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.1.80     Document Type: Article

References (40)

1. Cyclooxygenases 1 and 2
2. Colorectal cancer and nonsteroidal anti-inflammatory drugs
3. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
4. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low dose sulindac maintenance treatment
5. Chemoprevention of spontaneous intestinal adenoma in the adenomatous polyposis coli min mouse model with aspirin
6. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
7. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
8. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandin E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion)
9. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam
10. Localization of prostaglandin H synthase isozymes in murine epidermal tumors: Suppression of skin tumor promotion by PGHS-2 inhibition
11. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis
12. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
13. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
14. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
15. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
16. Prostaglandin H synthase isozyme expression in normal and neoplastic human skin
17. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
18. Cyclooxygenase-2 expression in human esophageal carcinoma
19. Expression of cyclooxygenase-2 in human lung carcinoma
20. Expression of cyclooxygenase-2 in human gastric carcinoma
21. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
22. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
23. Expression of cyclooxygenase-2 in hepatocellular carcinoma: Relevance to rumor dedifferentiation
24. Cyclooxygenase-2 expression in hepatocellular carcinoma
25. Localization of prostaglandin H synthase-1 and -2 in mouse skin: Implications for cutaneous function
26. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer
27. Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis
28. Cyclooxygenase in biology and disease
29. Expression of mRNA for cyclooxygenases-1 and cyclooxygenase-2 in human tissues
30. Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression
31. Proliferative responses of the skin to external stimuli
32. Effects of cyclooxygenase deficiency on inflammation and papilloma development in mouse skin
33. Opisthorchis viverrini infection and cholangiocarcinoma
34. A histopathologic study of 61 cases of peripheral intrahepatic cholangiocarcinoma
35. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma
36. Multistage carcinogenesis of liver-fluke-associated cholangiocarcinoma in Thailand
37. Strong promoting effect of opisthorchis viverrini infection on dimethylnitrosamine-initiated hamster liver
38. Aspirin-like molecules that covalently inactivate cyctooxygenase-2
39. Pharmacological analysis of cyclooxygenase-1 in inflammation
40. 3,4-Diarylpyrazoles: Potent and selective inhibitors of cyclooxygenase-2